Biomarker-Based Assessment: The identification of specific mitochondrial-associated oxidative stress biomarkers, such as Humanin, MOTS-c, and p66shc, provides a new avenue for assessing depression severity. This evidence concerns the gene MT-RNR2 and depressive symptom measurement.